Two pneumococcal vaccines are currently licensed for use in the United States: the 13-valent
pneumococcal conjugate vaccine (PCV13 [Prevnar 13, Wyeth Pharmaceuticals, Inc., a …

Importance A comprehensive understanding of the benefits of COVID-19 vaccination requires
consideration of disease attenuation, determined as whether people who develop COVID-…

Objectives To characterize the clinical severity of covid-19 associated with the alpha, delta,
and omicron SARS-CoV-2 variants among adults admitted to hospital and to compare the …

Background: As SARS-CoV-2 vaccination coverage increases in the United States (US), there
is a need to understand the real-world effectiveness against severe Covid-19 and among …

On October 20, 2021, the Advisory Committee on Immunization Practices recommended 15-valent
PCV (PCV15) or 20-valent PCV (PCV20) for PCV–naïve adults who are either aged≥ …

This report compiles and summarizes all published recommendations from CDC’s Advisory
Committee on Immunization Practices (ACIP) for use of pneumococcal vaccines in adults …

Psittacosis, also known as parrot fever and ornithosis, is a bacterial infection that can cause
severe pneumonia and other serious health problems in humans. It is caused by Chlamydia …

… Farrar J, Nsofor C, Childs L, Kobayashi M, Pilishvili T. Systematic review of 13-valent
pneumococcal conjugate vaccine effectiveness against pneumonia among children. 12th …

Background As severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
vaccination coverage increases in the United States, there is a need to understand the real-world …

Observational studies of the effectiveness of vaccines to prevent COVID-19 are needed to
inform real-world use. Such studies are now underway amid the ongoing rollout of SARS-CoV-…